No Data
No Data
Earnings Call Summary | Jaguar Health(JAGX.US) Q4 2024 Earnings Conference
Jaguar Health Outlines Key Q2 2025 Catalysts for Crofelemer Programs
Jaguar Health GAAP EPS of -$5.23, Revenue of $11.69M
Jaguar Health | 10-K: Annual report
Jaguar Health Announces Results of Veterinary Oncologists on Canalevia-CA1
Jaguar Health Meeting With FDA Regarding Results of Phase 3 OnTarget Study